Charles River Laboratories Inventory 2010-2024 | CRL

Charles River Laboratories inventory from 2010 to 2024. Inventory can be defined as the total value of inventories in all stages of completion.
  • Charles River Laboratories inventory for the quarter ending September 30, 2024 was $0.336B, a 14.75% increase year-over-year.
  • Charles River Laboratories inventory for 2023 was $0.38B, a 48.65% increase from 2022.
  • Charles River Laboratories inventory for 2022 was $0.256B, a 28.45% increase from 2021.
  • Charles River Laboratories inventory for 2021 was $0.199B, a 7.24% increase from 2020.
Charles River Laboratories Annual Inventory
(Millions of US $)
2023 $380
2022 $256
2021 $199
2020 $186
2019 $161
2018 $128
2017 $115
2016 $96
2015 $94
2014 $89
2013 $89
2012 $88
2011 $93
2010 $100
2009 $103
Charles River Laboratories Quarterly Inventory
(Millions of US $)
2024-09-30 $336
2024-06-30 $349
2024-03-31 $361
2023-12-31 $380
2023-09-30 $293
2023-06-30 $285
2023-03-31 $263
2022-12-31 $256
2022-09-30 $262
2022-06-30 $257
2022-03-31 $221
2021-12-31 $199
2021-09-30 $182
2021-06-30 $194
2021-03-31 $194
2020-12-31 $186
2020-09-30 $181
2020-06-30 $168
2020-03-31 $163
2019-12-31 $161
2019-09-30 $156
2019-06-30 $135
2019-03-31 $130
2018-12-31 $128
2018-09-30 $126
2018-06-30 $124
2018-03-31 $119
2017-12-31 $115
2017-09-30 $107
2017-06-30 $105
2017-03-31 $98
2016-12-31 $96
2016-09-30 $99
2016-06-30 $98
2016-03-31 $97
2015-12-31 $94
2015-09-30 $98
2015-06-30 $90
2015-03-31 $86
2014-12-31 $89
2014-09-30 $93
2014-06-30 $93
2014-03-31 $92
2013-12-31 $89
2013-09-30 $87
2013-06-30 $88
2013-03-31 $85
2012-12-31 $88
2012-09-30 $94
2012-06-30 $92
2012-03-31 $89
2011-12-31 $93
2011-09-30 $94
2011-06-30 $101
2011-03-31 $98
2010-12-31 $100
2010-09-30 $101
2010-06-30 $97
2010-03-31 $98
2009-12-31 $103
2009-09-30 $100
2009-06-30 $96
2009-03-31 $98
Sector Industry Market Cap Revenue
Medical Medical Services $10.011B $4.129B
Charles River Laboratories International, Inc. is a full service, early-stage contract research organization. The company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions globally accelerate their research and drug development efforts. The company has a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP. This helps support its clients from target identification through non-clinical development. Charles River also provides a line of products and services to support clients' manufacturing activities. Utilizing the company's broad portfolio of products and services, clients can create a more flexible drug development model, aiming cost reduction, productivity enhancement and increase in speed to market. Charles River currently has three reporting segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA) and Manufacturing Support.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $93.361B 11.58
Cencora (COR) United States $48.280B 17.81
DiDi Global (DIDIY) China $22.212B 0.00
Natera (NTRA) United States $22.082B 0.00
ICON (ICLR) Ireland $17.675B 15.74
Viatris (VTRS) United States $15.958B 4.92
Avantor (AVTR) United States $14.143B 21.20
Revvity (RVTY) United States $13.634B 23.68
CochLear (CHEOY) Australia $12.777B 0.00
Solventum (SOLV) United States $12.233B 0.00
BioMerieux (BMXMF) France $11.895B 0.00
Medpace Holdings (MEDP) United States $10.498B 29.58
HealthEquity (HQY) United States $9.104B 49.41
Doximity (DOCS) United States $8.999B 52.97
Sonic Healthcare (SKHHY) Australia $8.862B 0.00
Bausch + Lomb (BLCO) Canada $6.892B 32.08
Life Times (LTH) United States $5.081B 33.63
Organon (OGN) United States $3.935B 3.97
Sotera Health (SHC) United States $3.631B 19.42
BrightSpring Health Services (BTSG) United States $3.265B 69.44
Surgery Partners (SGRY) United States $2.925B 33.35
Concentras Parent (CON) United States $2.789B 0.00
PACS (PACS) United States $2.515B 0.00
Alignment Healthcare (ALHC) United States $2.310B 0.00
Ardent Health Partners (ARDT) United States $2.259B 0.00
Premier (PINC) United States $2.195B 11.42
GeneDx Holdings (WGS) United States $2.162B 0.00
Ryman Healthcare (RYHTY) New Zealand $1.995B 0.00
GoodRx Holdings (GDRX) United States $1.868B 49.00
Teladoc Health (TDOC) United States $1.828B 0.00
Progyny (PGNY) United States $1.315B 26.62
Pediatrix Medical (MD) United States $1.285B 12.57
CareDx (CDNA) United States $1.241B 0.00
Establishment Labs Holdings (ESTA) $1.206B 0.00
AMN Healthcare Services Inc (AMN) United States $0.984B 6.66
Embecta (EMBC) United States $0.797B 5.32
QDM (QDMI) Hong Kong, SAR China $0.790B 0.00
Agilon Health (AGL) United States $0.779B 0.00
SBC Medicals (SBC) United States $0.674B 0.00
InnovAge Holding (INNV) United States $0.662B 0.00
Auna S.A (AUNA) Luxembourg $0.522B 0.00
Sonida Senior Living (SNDA) United States $0.474B 0.00
DocGo (DCGO) United States $0.434B 16.35
Enhabit (EHAB) United States $0.380B 32.87
COMPASS Pathways (CMPS) United Kingdom $0.302B 0.00
ModivCare (MODV) United States $0.254B 13.79
LifeMD (LFMD) United States $0.251B 0.00
Sera Prognostics (SERA) United States $0.221B 0.00
Biodesix (BDSX) United States $0.186B 0.00
Nutex Health (NUTX) United States $0.179B 0.00
Beauty Health (SKIN) United States $0.176B 0.00
MultiPlan (MPLN) United States $0.112B 0.00
So-Young (SY) China $0.086B 16.60
Ascend Wellness Holdings (AAWH) United States $0.085B 0.00
Singular Genomics Systems (OMIC) United States $0.054B 0.00
OncoCyte (OCX) United States $0.046B 0.00
NeueHealth (NEUE) United States $0.041B 1.10
IceCure Medical (ICCM) Israel $0.032B 0.00
Co-Diagnostics (CODX) United States $0.032B 0.00
Pheton Holdings (PTHL) China $0.031B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.021B 0.00
Oncology Institute (TOI) United States $0.012B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
XWELL (XWEL) United States $0.008B 0.00
Intelligent Bio Solutions (INBS) United States $0.007B 0.00
KindlyMD (KDLY) United States $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00